Enhanced drug metabolism in young children with cystic fibrosis
a Institute of Child Health, Alder Hey Children's
Hospital, Liverpool, b Scottish Universities Research and
Reactor Centre, East Kilbride, Scotland
Correspondence to: Professor I Choonara, Academic Division of Child Health, Derbyshire Children's Hospital, Uttoxeter Road, Derby DE22 3NE.
Accepted 16 June
1997
The effect of cystic fibrosis on caffeine metabolism was
studied in young children using the caffeine breath test. Eight
children with cystic fibrosis aged 2-6 years and nine age matched
controls were studied on a single occasion, and the cumulative
percentage of labelled caffeine exhaled as carbon dioxide measured over
two hours. This was significantly higher in the patients with cystic fibrosis than in controls, suggesting an increase in the CYP1A2 metabolic pathway in the former. The fact that these were young children with minimal lung and liver disease suggests that enhanced drug metabolism in children with cystic fibrosis is hereditary rather
than secondary to lung and liver damage.
© 1997 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Bradford, E. M., Sartor, M. A., Gawenis, L. R., Clarke, L. L., Shull, G. E.
(2009). Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice. Am. J. Physiol. Gastrointest. Liver Physiol.
296: G886-G898
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



